168 related articles for article (PubMed ID: 25811459)
1. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
[TBL] [Abstract][Full Text] [Related]
3. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
[TBL] [Abstract][Full Text] [Related]
4. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
[TBL] [Abstract][Full Text] [Related]
6. Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
Deville JL; Gravis G; Salem N; Savoie PH; Esterni B; Walz J; Thomas P; Goncalves A; Viens P; Bladou F
Eur J Cancer Care (Engl); 2010 Nov; 19(6):827-32. PubMed ID: 19708949
[TBL] [Abstract][Full Text] [Related]
7. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
Siesing C; Sorbye H; Dragomir A; Pfeiffer P; Qvortrup C; Pontén F; Jirström K; Glimelius B; Eberhard J
PLoS One; 2017; 12(8):e0182512. PubMed ID: 28800641
[TBL] [Abstract][Full Text] [Related]
8. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
Ye F; Jin P; Cai X; Cai P; Cai H
Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
[TBL] [Abstract][Full Text] [Related]
9. Brachyury oncogene is a prognostic factor in high-risk testicular germ cell tumors.
Pinto F; Cárcano FM; da Silva ECA; Vidal DO; Scapulatempo-Neto C; Lopes LF; Reis RM
Andrology; 2018 Jul; 6(4):597-604. PubMed ID: 29749711
[TBL] [Abstract][Full Text] [Related]
10. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
Biomark Res; 2014; 2():11. PubMed ID: 24963396
[TBL] [Abstract][Full Text] [Related]
11. Incorporating age into International Germ Cell Consensus Classification (IGCCC): a time to move forward?
Abdel-Rahman O
Expert Rev Anticancer Ther; 2018 Jan; 18(1):101-105. PubMed ID: 29115166
[TBL] [Abstract][Full Text] [Related]
12. Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours.
Gilbert DC; Chandler I; Summersgill B; McIntyre A; Missiaglia E; Goddard NC; Huddart RA; Shipley J
Int J Androl; 2011 Aug; 34(4 Pt 2):e114-21; discussion e121. PubMed ID: 21615418
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
Biomark Res; 2017; 5():10. PubMed ID: 28293425
[TBL] [Abstract][Full Text] [Related]
14. The management and outcome of patients with germ-cell tumours treated in the Edinburgh Cancer Centre between 1988 and 2002.
Howard GC; Conkey DS; Peoples S; McLaren DB; Hargreave TB; Tulloch DN; Walker W; Kerr GR
Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):435-40. PubMed ID: 16149287
[TBL] [Abstract][Full Text] [Related]
15. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group.
Frazier AL; Rumcheva P; Olson T; Giller R; Cushing B; Cullen J; Marina N; London WB;
Pediatr Blood Cancer; 2008 Apr; 50(4):746-51. PubMed ID: 18085675
[TBL] [Abstract][Full Text] [Related]
16. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
17. Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer.
Melling N; Simon R; Mirlacher M; Izbicki JR; Stahl P; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Histopathology; 2016 Jan; 68(2):191-8. PubMed ID: 25922889
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.
Pectasides D; Papaxoinis G; Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Pectasides E; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos T
Anticancer Res; 2009 Feb; 29(2):737-44. PubMed ID: 19331230
[TBL] [Abstract][Full Text] [Related]
19. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.
Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
[TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators for failure of surveillance management of stage I non-seminomatous germ cell tumours.
Costello AJ; Mortensen PH; Stillwell RG
Aust N Z J Surg; 1989 Feb; 59(2):119-22. PubMed ID: 2537616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
